Neurogene Inc. (NGNE)
NASDAQ·Healthcare·Biotechnology
$34.25
+4.37%
Mkt Cap $519.74M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (15 analysts)
$69.67
Range $69.00 – $70.00
Implied Upside
+103.4%
Consensus $69.67 vs current $34.25
NASDAQ·Healthcare·Biotechnology
$34.25
+4.37%
Mkt Cap $519.74M
Buy
2
Hold
0
Sell
0
Price Target (15 analysts)
$69.67
Range $69.00 – $70.00
+103.4%
Consensus $69.67 vs current $34.25